PRN: Global Cardiovascular Partnering Analysis 2010-2016: Deal Trends, Players and Financials

04/feb/2016 13:11:32 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cardiovascular Partnering Analysis 2010-2016: Deal Trends, Players and Financials


DUBLIN, Feb. 4, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials" company profile to their offering.

Global Cardiovascular Partnering 2010 to 2016 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.

The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope

  • Trends in cardiovascular dealmaking in the biopharma industry since 2010
  • Analysis of cardiovascular deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to over 1,000 cardiovascular deal records
  • The leading cardiovascular deals by value since 2010

In Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in Cardiovascular dealmaking

Chapter 3 - Financial deal terms for Cardiovascular partnering

Chapter 4 - Leading Cardiovascular deals and dealmakers

Chapter 5 - Cardiovascular contract document directory

Chapter 6 - Cardiovascular dealmaking by therapeutic target

For more information visit

Media Contact:

Laura Wood , +353-1-481-1716,



blog comments powered by Disqus è un servizio offerto da Factotum Srl